Mark Bachleda

Chief Commercial Officer, Galera Therapeutics, Inc.

Companies

Lyell Immunopharma, Inc.Board member Jun 11, 2025 to now¹
Galera Therapeutics, Inc.Chief Commercial Officer Oct 12, 2021 to Mar 20, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Galera Therapeutics, Inc.11,000 shares³Mar 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 16, 2023Bought 11,000 shares at $2.25 of Galera Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLyell Immunopharma, Inc., Board member
2
SEC EDGARGalera Therapeutics, Inc., Chief Commercial Officer
3
SEC EDGARGalera Therapeutics, Inc. shares after the filing of Mar 16, 2023